An observational study in Smoking Cessation, Brachial Flow Mediated Dilatation and Nicotine Replacement Therapy, sponsored by Instituto Fernandes Figueira. Completed at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-24.
Sponsored by Instituto Fernandes Figueira · Observational
The study was carried out within a large, urban prospective cohort of PLHIV at the Instituto Nacional de Infectologia Evandro Chagas (INI). Located in Rio de Janeiro, Brazil, INI is a national public referral center for PLWHA receiving primary care since 1998. From December 2019, adults who had attitudes toward quitting smoking and had no contraindications to study pharmacotherapy were enrolled by active site searching
260 studies on the registry are indexed under Dilatation, Pathologic; 43 are open to participants now.
This study's enrollment of 115 is above the median of 94 across 64 observational studies indexed under Dilatation, Pathologic.
Browse Dilatation, Pathologic studies →Instituto Fernandes Figueira is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults HIV positive who had attitudes toward quitting smoking and had no contraindications to study pharmacotherapy
Exclusion Criteria:
Relapse
Drug: Nicotine replacement
Smoking cessation
Drug: Nicotine replacement
Nicotine patches
FMD
Flow mediated brachial artery dilatation
Time frame: 12 months
Plan to share: No — Upon request data will be shared , anonimyzed
No publications or documents are linked to this record.
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Fernandes Figueira